58 DAFTAR PUSTAKA
1. Hoffbrand AV, Moss PAH. Kapita selekta hematologi. Edisi ke 6. Jakarta:
EGC, 2013.
2. Fadjari H, Sukrisman L. Leukemia granulosisitk kronis. Dalam: Sudoyo AW, Setiohadi B, Alwi I, dkk (editor). Buku ajar ilmu penyakit dalam, edisi ke-5.
Jakarta: Interna publishing, 2009:1209-13.
3. Kota V, Natarajan K. Definition, epidemiology, natural history and clinical phases. In: Chronic Myeloid Leukemia. Nova Publisher, 2014.
4. Marfe G, Stefano CD. Cancer stem cells in chronic myelogenous leukemia. J Leuk, 2014; 1-7.
5. Champlin R, Jabbour E, Kebriaei P, et al. Allogeneic stem cell transplantation for chronic myeloid leukemia resistant to tyrosine kinase inhibitors. Clin Lymphoma Myeloma Leuk, 2011; 96-100.
6. Nair AP, Barnett MJ, Broady RC, et al. Allogenic hematopoietic stem cell transplantation is an effective salvage therapy for patients with chronic myeloid leukemia presenting with advanced disease or failing treatment with tyrosine kinase inhibitors. Biol Blood Marrow Transplant, 2015; 21: 1437-44.
7. Reksodiputro AH. Transplantasi sel punca/induk darah. Dalam: Sudoyo AW, Setiohadi B, Alwi I, dkk (editor). Buku ajar ilmu penyakit dalam, edisi ke-5.
Jakarta: Interna publishing, 2009:1394-400.
8. Halim D, Murti H, Sandra F, dkk. Stem cell dasar teori dan aplikasi. Jakarta:
EMS, 2010.
9. Herberts CA, Kwa MSG, Hermsen HPH. Risk factors in the development of stem cell therapy. J of Translational Med, 2011; 9-29.
10. Hanafiah MJ, Amir A. Etika kedokteran & hukum kesehatan. Jakarta: EGC, 2008.
11. Zuhroni. Pandangan Islam terhadap masalah kedokteran dan kesehatan.
Jakarta: Bagian Agama Universitas Yarsi, 2010.
12. Zuhroni. Hukum Islam terhadap berbagai masalah kedokteran dan kesehatan kontemporer. Jakarta: Balai Agama Universitas Yarsi, 2012.
13. Jabbour E, Kantarjian H. Chronic myeloid leukemia. Am J Hematol; 87:1037- 45.
59 14. Bubnof NV, Duyster J. Chronic myelogenous leukemia. Dtsch Arztebl Int,
2010; 107(7): 114-21.
15. Bhatia R. Chronic myeloid leukemia. In: Hematology: basic principles and practice. Elsevier, 2013.
16. Gugliotta G, Castagnetti F, Apolinari M, et al. First-line treatment of newly diagnosed elderly patients with chronic myeloid leukemia: current and emerging strategies. Drugs, 2014; 74: 627-43.
17. Jootar, S., CML treatment in Asia-Pacific region. Hematology, 2012. 17 Suppl 1: p. S72-4.
18. Vardiman JW, Thiele J, Arber DA, et al., The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood, 2009. 114(5): p. 937-51.
19. Dolan M, Spear M, Yohe S. Cytogenetic and molecular aspects of CML. In:
Chronic Myeloid Leukemia. Nova Publisher, 2014.
20. Goldman JM, Melo JV. Chronic myeloid leukemia - advances in biology and new approaches to treatment. N Engl J Med, 2003; 349:1451-64.
21. Jiang Q, Xu LP, Liu DH, et al. Imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in the accelerated phase. Blood, 2011; 117(11):3032-3040.
22. Bejanyan N. CML: Clinical diagnosis, differential diagnosis and scoring Systems In: Chronic Myeloid Leukemia. Nova Publisher, 2014.
23. Baldy CM. Gangguan sel darah putih dan sel plasma. Dalam: Price SA, Wilson LM. Patofisiologi. Edisi ke 6, Volume 1. Jakarta: EGC, 2006.
24. Vaidya S, Joshi D, Ghosh K, et al. A novel 5-way translocation t(9;11;13;19;22) in a case of chronic-phase chronic myeloid leukemia. Human pathology, 2013; 44: 2365-9.
25. Tashfeen S, Ahmed S, Bhatti FA, et al. Real time polymerase chain reaction in diagnosis of chronic myeloid leukemia. Department of haematol, 2013; 190-3.
26. He F, Warlick ED. Hematopoietic cell transplant for CML In: Chronic Myeloid Leukemia. Nova Publisher, 2014.
27. Mehta AB, Hoffbrand AV. At a glance hematologi. Edisi ke 2. Jakarta:
Erlangga, 2008.
60 28. National Institutes of Health. Stem cell basic (image on the Internet).
2015.Diunduh dari http://stemcells.nih.gov/info/basics/pages/basics4.aspx.
diakses 26 Februari 2016 00:21.
29. Irawan C. Sel punca (stem cell) dan potensi klinisnya. Dalam: Sudoyo AW, Setiohadi B, Alwi I, dkk (editor). Buku ajar ilmu penyakit dalam, edisi ke-5.
Jakarta: Interna publishing, 2009:1401-5.
30. Berro M, Basquiera AL, Rivas MM, et al. Allogenic hematopoietic transplantation in elderly, predicting the risk for non relapse mortality.
MEDICINA (Buenos Aires), 2015;75: 201-6.
31. Ustun C, Warlick ED, Bose P, et al. Summary of treatment and recommended follow-up of CML patients. In: Chronic Myeloid Leukemia. Nova Publisher, 2014.
32. Bhamidipati PK, Jabbour E. Frontline therapy. In: Chronic Myeloid Leukemia. Nova Publisher, 2014.
33. Allogenic bone marrow transplant (image on the Internet). Diunduh dari http://www.bonemarrowmx.com/allogeneic-bone-marrow-transplant/, diakses 26 Februari 2016 01:21.
34. Al-Jauziyah. Praktek Kedokteran Nabi. Jogjakarta: Hikam Pustaka, 2013.
35. Zuhroni, Riani N, Naarudin N. Islam untuk Disiplin Ilmu Kesehatan dan Kedokteran 2 (Fiqh Kontemporer). Jakarta: Departemen Agama RI Direktorat Jenderal Kelembagaan Agama Islam, 2003.
36. Zuhroni. Pandangan Islam Terhadap Masalah Kedokteran dan Kesehatan..
Jakarta: Bagian Agama Universitas Yarsi, 2008.
37. Fadel, HE. Prospect and ethics of stem cell research: an Islamic perspective.
JIMA, 2008; 39:27.
